Merlin Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $488K | Sell |
17,724
-9,110
| -34% | -$251K | 1.45% | 39 |
|
|
2023
Q4 | $818K | Buy |
26,834
+8,308
| +45% | +$253K | 2.62% | 4 |
|
|
2023
Q3 | $586K | Buy |
18,526
+885
| +5% | +$28K | 2.19% | 19 |
|
|
2023
Q2 | $719K | Buy |
17,641
+5,031
| +40% | +$205K | 2.43% | 11 |
|
|
2023
Q1 | $470K | Buy |
12,610
+307
| +2% | +$11.4K | 1.7% | 33 |
|
|
2022
Q4 | $429K | Buy |
12,303
+646
| +6% | +$22.5K | 1.06% | 46 |
|
|
2022
Q3 | $652K | Sell |
11,657
-517
| -4% | -$28.9K | 1.51% | 19 |
|
|
2022
Q2 | $630K | Buy |
12,174
+599
| +5% | +$31K | 1.26% | 25 |
|
|
2022
Q1 | $841K | Buy |
11,575
+5,020
| +77% | +$365K | 1.11% | 22 |
|
|
2021
Q4 | $775K | Buy |
+6,555
| New | +$775K | 0.9% | 38 |
|